当前位置：
X-MOL 学术
›
Respir. Physiol. Neurobiol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Pros and cons of corticosteroid therapy for COVID-19 patients.
Respiratory Physiology & Neurobiology ( IF 2.3 ) Pub Date : 2020-07-10 , DOI: 10.1016/j.resp.2020.103492 Paula Mattos-Silva 1 , Nathane Santanna Felix 1 , Pedro Leme Silva 1 , Chiara Robba 2 , Denise Battaglini 2 , Paolo Pelosi 3 , Patricia Rieken Macedo Rocco 1 , Fernanda Ferreira Cruz 1
更新日期：2020-07-14
Respiratory Physiology & Neurobiology ( IF 2.3 ) Pub Date : 2020-07-10 , DOI: 10.1016/j.resp.2020.103492 Paula Mattos-Silva 1 , Nathane Santanna Felix 1 , Pedro Leme Silva 1 , Chiara Robba 2 , Denise Battaglini 2 , Paolo Pelosi 3 , Patricia Rieken Macedo Rocco 1 , Fernanda Ferreira Cruz 1
Affiliation
In December 2019, an outbreak of severe pneumonia was reported in Wuhan, China. Later described as COVID-19 (coronavirus disease 2019), this infection caused by a virus from the Coronaviridae family (SARS-CoV-2) has spread globally. Effective therapies for this new disease are urgently needed. In this short communication, we will evaluate the use of corticosteroids as an adjunctive pharmacological therapy in the management of COVID-19 and describe its pros and cons in light of the latest available evidence.
京公网安备 11010802027423号